Caroline Apovian

Caroline Apovian is a leading authority on obesity medicine whose research on adipokine biology and insulin resistance has elucidated the biological mechanisms connecting excess adiposity to cancer risk, providing the scientific rationale for metabolic surgery as a cancer prevention strategy. Her work on anti-obesity medications has expanded the non-surgical treatment landscape while defining the subset of patients who benefit most from surgical intervention. She contributes to national guidelines that increasingly recognize cancer prevention as an indication for metabolic surgery.